No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acinetobacter Infections / drug therapy
-
Acinetobacter Infections / epidemiology
-
Acinetobacter Infections / microbiology
-
Acinetobacter baumannii / classification
-
Acinetobacter baumannii / drug effects
-
Acinetobacter baumannii / genetics*
-
Acinetobacter baumannii / isolation & purification
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Proteins / genetics*
-
Bacterial Proteins / metabolism
-
Carbapenems / pharmacology
-
Clone Cells
-
Electrophoresis, Gel, Pulsed-Field
-
Gene Expression
-
Hospitals
-
Humans
-
Isoenzymes / genetics
-
Isoenzymes / metabolism
-
Mexico / epidemiology
-
Microbial Sensitivity Tests
-
Public Health Surveillance
-
beta-Lactam Resistance / genetics*
-
beta-Lactamases / genetics*
-
beta-Lactamases / metabolism
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Carbapenems
-
Isoenzymes
-
OXA-72 carbapenemase, Acinetobacter baumannii
-
beta-Lactamases
Grants and funding
This work was funded by Consejo Nacional de Ciencia y Tecnología (CONACYT) through SEPCONACYT grant numbers 169867, 136339, 130224, and 205707. A.M.G.-V. was a Ph.D. fellow from CONACYT.